.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Queensland Health
Dow
Johnson and Johnson
Farmers Insurance
Novartis
Chinese Patent Office
Cipla
Deloitte
Express Scripts

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040771

« Back to Dashboard
NDA 040771 describes TRIAMCINOLONE ACETONIDE, which is a drug marketed by Mylan Pharms Inc, Taro, Parnell, Perrigo Israel, Teligent Pharma Inc, Pharmafair, Akorn, Perrigo New York, Alpharma Us Pharms, Glenmark Pharms Ltd, Watson Labs, G And W Labs Inc, Ambix, Wockhardt Eu Operatn, Wockhardt, Lupin Atlantis, Sandoz Inc, Fougera Pharms, Vintage, Lyne, Topiderm, Perrigo Uk Finco, Pharmaderm, Morton Grove, G And W Labs, Actavis Mid Atlantic, and Cmp Pharma Inc, and is included in seventy-three NDAs. It is available from fifty-six suppliers. Additional details are available on the TRIAMCINOLONE ACETONIDE profile page.

The generic ingredient in TRIAMCINOLONE ACETONIDE is triamcinolone acetonide. There are fifty drug master file entries for this compound. Eighty-two suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Summary for NDA: 040771

Pharmacology for NDA: 040771

Suppliers and Packaging for NDA: 040771

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
PASTE;DENTAL 040771 ANDA Rebel Distributors Corp 21695-641 21695-641-05 1 TUBE in 1 CARTON (21695-641-05) > 5 g in 1 TUBE
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
PASTE;DENTAL 040771 ANDA AvKARE, Inc. 42291-840 42291-840-05 48 CARTON in 1 BOX (42291-840-05) > 1 TUBE in 1 CARTON > 5 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:PASTE;DENTALStrength0.1%
Approval Date:Jul 1, 2010TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Dow
Fish and Richardson
Harvard Business School
AstraZeneca
Covington
Cerilliant
Queensland Health
Moodys
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot